<?xml version="1.0" encoding="UTF-8"?>
<ref id="B151-antibiotics-09-00353">
 <label>151.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Beshbishy</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Batiha</surname>
    <given-names>G.E.-S.</given-names>
   </name>
   <name>
    <surname>Alkazmi</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Nadwa</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Rashwan</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Abdeen</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Yokoyama</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Igarashi</surname>
    <given-names>I.</given-names>
   </name>
  </person-group>
  <article-title>Therapeutic Effects of Atranorin towards the Proliferation of Babesia and Theileria Parasites</article-title>
  <source>Pathogens</source>
  <year>2020</year>
  <volume>9</volume>
  <elocation-id>127</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pathogens9020127</pub-id>
 </element-citation>
</ref>
